No profile data available.
Vera Therapeutics, Inc. (VERA) is a healthcare company in the urinary system treatment drugs industry, based in Brisbane, United States, with about 361 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$299.62 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $2.15 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases.
Vera Therapeutics reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$2.15 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (urinary system treatment drugs) include Travere Therapeutics, Inc. (TVTX), ProKidney Corp. (PROK), Akebia Therapeutics, Inc. (AKBA), Jyong Biotech Ltd. (MENS).